Cajal Therapeutics
Seattle, United States · Founded 2020 · $96.0M raised
- Headquarters
- Seattle, Washington
- Founded
- 2020
- Business Model
- B2B
- Website
- cajal-tx.com
- Total Funding
- $96.0M
- Last Round
- $96.0M Series ANov 2022
- Rounds
- 1
About
Seattle biotech developing disease-altering therapies for neurodegenerative diseases and anemias.
Summary
Cajal Therapeutics is a Biotech company based in Seattle, United States, founded in 2020. It has raised $96.0M in total across 1 round, most recently a $96.0M Series A round in Nov 2022. Investors include The Column Group, Lux Capital and Two Sigma Ventures.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Nov 2022
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...